Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Deucrictibant [inn]
2. 69gca2kx22
3. Pha-121
4. Unii-69gca2kx22
5. Phvs-719
6. Pha-022121
7. 2340111-58-0
8. (s)-n-(1-deutero-1-(3-chloro-5-fluoro-2-((2-methyl-4-(1-methyl-1h-1,2,4-triazol-5-yl)quinolin-8-yloxy)methyl)phenyl)ethyl)-2-(difluoromethoxy)acetamide
9. Acetamide, N-((1s)-1-(3-chloro-5-fluoro-2-(((2-methyl-4-(1-methyl-1h-1,2,4-triazol-5-yl)-8-quinolinyl)oxy)methyl)phenyl)ethyl-1-d)-2-(difluoromethoxy)-
10. Chembl5095059
11. Schembl22320140
12. Gtpl12421
13. Glxc-26832
14. Pha022121
15. Hy-145562
16. Cs-0376051
17. N-[(1s)-1-[3-chloro-5-fluoro-2-({[2-methyl-4-(1-methyl-1h-1,2,4-triazol-5-yl)quinolin-8-yl]oxy}methyl)phenyl](1-2h)ethyl]-2-(difluoromethoxy)acetamide
18. N-[(1s)-1-[3-chloro-5-fluoro-2-[[2-methyl-4-(2-methyl-1,2,4-triazol-3-yl)quinolin-8-yl]oxymethyl]phenyl]-1-deuterioethyl]-2-(difluoromethoxy)acetamide
| Molecular Weight | 534.9 g/mol |
|---|---|
| Molecular Formula | C25H23ClF3N5O3 |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 9 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 91.2 |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 758 |
| Isotope Atom Count | 1 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
29
PharmaCompass offers a list of Deucrictibant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Deucrictibant manufacturer or Deucrictibant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Deucrictibant manufacturer or Deucrictibant supplier.
PharmaCompass also assists you with knowing the Deucrictibant API Price utilized in the formulation of products. Deucrictibant API Price is not always fixed or binding as the Deucrictibant Price is obtained through a variety of data sources. The Deucrictibant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Deucrictibant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deucrictibant, including repackagers and relabelers. The FDA regulates Deucrictibant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deucrictibant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Deucrictibant supplier is an individual or a company that provides Deucrictibant active pharmaceutical ingredient (API) or Deucrictibant finished formulations upon request. The Deucrictibant suppliers may include Deucrictibant API manufacturers, exporters, distributors and traders.
Deucrictibant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Deucrictibant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Deucrictibant GMP manufacturer or Deucrictibant GMP API supplier for your needs.
A Deucrictibant CoA (Certificate of Analysis) is a formal document that attests to Deucrictibant's compliance with Deucrictibant specifications and serves as a tool for batch-level quality control.
Deucrictibant CoA mostly includes findings from lab analyses of a specific batch. For each Deucrictibant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Deucrictibant may be tested according to a variety of international standards, such as European Pharmacopoeia (Deucrictibant EP), Deucrictibant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Deucrictibant USP).
